Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

[The value of acetylsalicylic acid in retinal vein occlusion].

Mazinani B, Plange N, Walter P.

Ophthalmologe. 2010 Nov;107(11):1081; author reply 1081-2. doi: 10.1007/s00347-010-2287-4. German. No abstract available.

PMID:
21088952
2.

Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.

Lippi G, Franchini M, Targher G.

Thromb Haemost. 2007 Jun;97(6):1059-60. No abstract available.

PMID:
17549315
3.

Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.

Masood I.

Am J Ophthalmol. 2005 Jul;140(1):167; author reply 167. No abstract available.

PMID:
16038677
4.
5.

The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion.

Ozkiris A, Evereklioglu C, Erkiliç K, Ilhan O.

Eur J Ophthalmol. 2005 Jan-Feb;15(1):96-101.

PMID:
15751246
6.

Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.

Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I.

Retina. 2010 Jun;30(6):893-902. doi: 10.1097/IAE.0b013e3181cd4894.

PMID:
20531142
7.

[Initial and unique treatment of macular edema due to branch retinal vein occlusion with antiangiogenic agents. A comparative pilot study].

Gallego-Pinazo R, Francés E, Gómez MJ, López R, Díaz-Llopis M.

Arch Soc Esp Oftalmol. 2009 May;84(5):229-30. Spanish. No abstract available.

8.

Consecutive central retinal artery and vein occlusions in primary antiphospholipid syndrome.

Levy J, Baumgarten A, Rosenthal G, Rabinowitz R, Lifshitz T.

Retina. 2002 Dec;22(6):784-6. No abstract available.

PMID:
12476107
9.

Steroids for branch retinal vein occlusion.

Kaiser PK.

Am J Ophthalmol. 2005 Jun;139(6):1095-6. No abstract available.

PMID:
15953443
10.

Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.

Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S.

Am J Ophthalmol. 2004 Nov;138(5):809-17.

PMID:
15531317
12.
13.

Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.

Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghirarduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D'Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D.

Thromb Res. 2010 Feb;125(2):137-41. doi: 10.1016/j.thromres.2009.05.007. Epub 2009 May 27.

PMID:
19477488
14.
15.

Pegaptanib for branch retinal vein occlusion.

Wong I, Koo S, Chan C.

Am J Ophthalmol. 2010 Jul;150(1):129; author reply 129-30. doi: 10.1016/j.ajo.2010.03.017. No abstract available.

PMID:
20609713
16.

Antithrombotic effect of ticlopidine in an experimental model of retinal vein occlusion.

Arroyo JG, Dastgheib K, Hatchell DL.

Jpn J Ophthalmol. 2001 Jul-Aug;45(4):359-62.

PMID:
11485766
17.

Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion.

Wakabayashi T, Okada AA, Morimura Y, Kojima E, Asano Y, Hirakata A, Hida T.

Retina. 2004 Dec;24(6):964-7. No abstract available.

PMID:
15579998
18.

Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid.

Farahvash MS, Moghaddam MM, Moghimi S, Mohammadzadeh S.

Can J Ophthalmol. 2008 Feb;43(1):79-83. doi: 10.3129/i07-190.

PMID:
18219348
19.

[Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].

de Lange DW, Fiets WE, Banga JD.

Ned Tijdschr Geneeskd. 2004 Jul 24;148(30):1481-5. Review. Dutch.

PMID:
15481570
20.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

Cekiç O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
Items per page

Supplemental Content

Write to the Help Desk